Alkermes
ALKS
#2139
Rank
NZ$16.27 B
Marketcap
NZ$97.62
Share price
4.26%
Change (1 day)
106.91%
Change (1 year)

Alkermes (ALKS) - Total debt

Total debt on the balance sheet as of March 2026 : NZ$2.80 Billion

According to Alkermes's latest financial reports the company's total debt is NZ$2.80 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Alkermes - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-12-31NZ$0.12 B-9.76%
2024-12-31NZ$0.13 B-77.24%
2023-12-31NZ$0.58 B-1.52%
2022-12-31NZ$0.59 B-1.92%
2021-12-31NZ$0.60 B7.19%
2020-12-31NZ$0.56 B31.58%
2019-12-31NZ$0.43 B3.75%
2018-12-31NZ$0.41 B5.08%
2017-12-31NZ$0.39 B-3.23%
2016-12-31NZ$0.40 B-19.91%
2015-12-31NZ$0.51 B12.61%
2014-12-31NZ$0.45 B
2013-03-31NZ$0.44 B-18.64%
2012-03-31NZ$0.54 B
2010-03-31NZ$72.11 M-46.12%
2009-03-31NZ$0.13 B-32.9%
2008-03-31NZ$0.19 B-9.93%
2007-03-31NZ$0.22 B-52.37%
2006-03-31NZ$0.46 B19.15%
2005-03-31NZ$0.39 B104.6%
2004-03-31NZ$0.19 B-39.44%
2003-03-31NZ$0.31 B-37.43%
2002-03-31NZ$0.50 B-10.28%
2001-03-31NZ$0.56 B21.52%
2000-03-31NZ$0.46 B531.42%
1999-03-31NZ$73.11 M130.3%
1998-03-31NZ$31.74 M52.51%
1997-03-31NZ$20.81 M11.39%
1996-03-31NZ$18.68 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$97.45 B 3,376.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$83.29 B 2,871.44%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$112.94 B 3,929.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$41.06 B 1,365.09%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$82.28 B 2,835.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$60.11 B 2,044.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$0.34 B-87.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$29.96 B 968.94%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel